C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/00 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61K 31/52 (2006.01) C07D 403/02 (2006.01) C07D 471/04 (2006.01) C07D 487/04 (2006.01)
Patent
CA 2134986
2134986 9323396 PCTABS00028 Compounds of formula (I) wherein Q represents the residue of a six-membered aromatic or heteroaromatic nucleus containing zero, one or two nitrogen atoms; V represents nitrogen or C-A2; E represents a bond or a straight or branched alkylene chain containing from 1 to 4 carbon atoms; F represents a group of formula (a); U represents nitrogen or C-R2; B represents oxygen, sulphur or N-R3; R1 represents -CH2.CHR4.NR6R7 or a group of formula (i), (ii), (iii) or (iv); are selective agonists of 5-HT1-like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.
Merck Sharp & Dohme Limited
Ogilvy Renault
LandOfFree
Fused imidazole and triazole derivatives as 5-htl receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused imidazole and triazole derivatives as 5-htl receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused imidazole and triazole derivatives as 5-htl receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1722936